CTKB R&D to Revenue
Cytek Biosciences Inc · R&D to Revenue
CTKB R&D to Revenue
Latest reported18.10%period ending
CTKB FY R&D/Revenue (15.43% → 18.10%)
Latest values, visible window
High-resolution chart · PNG
CTKB r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 18.0989% | |
| 19.6565% | |
| 22.8744% | |
| 21.2502% | |
| 19.1028% | |
| 14.7492% | |
| 15.4294% |